Search:
Filter:
Post type:
Sort:
According to court documents, from at least July 2023 to April 2024, the men allegedly obtained the counterfeit products, which included the packaging, pen labels, and needles, from unauthorized sources in China.
United States District Court Northern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Jennifer Stechkober Filed July 2026 Read the document.
United States District CourtNorthern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Matthew Kawa Filed July 2026 Read the document.
United States District Court Northern District of Indiana USA v Matthew Kawa, et al Judgment, Jennifer Stechkober Filed July 2026 Read the document.
United States District CourtNorthern District of Indiana USA v Matthew Kawa, et al Judgment, Matthew Kawa Filed July 2026 Read the document.
United States District Court Northern District of Indiana USA v Matthew Kawa, et al Plea agreement, Jennifer Stechkober Filed October 2025 Read the document.
United States District Court Northern District of Indiana USA v Matthew Kawa, et al Information Filed October 2025 Read the document.
The Texas-based 503A compounding facility was warned for continuing to manufacture large amounts of weight loss drugs that are “essentially copies” of brand-name products, which is no longer permitted now that shortages have resolved.
United States District Court Middle District of Florida USA v Swapnadip Roy and Vicky Ramancha Notice of Corporate Victims Filed September 2026 Read the document.
United States District Court Middle District of Florida USA v Swapnadip Roy and Vicky Ramancha Indictment Filed September 2025 Read the document.